Fonte: Journal of Pharmacology and Experimental Therapeutics. Unidade: FMRP
Assuntos: INFLAMAÇÃO, FÁRMACOS, BIOLOGIA MOLECULAR
ABNT
NAPIMOGA, Marcelo H. et al. 15d-Prostaglandin 'J IND. 2' inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Journal of Pharmacology and Experimental Therapeutics, v. 324, n. 1, p. 313-321, 2008Tradução . . Acesso em: 22 ago. 2024.APA
Napimoga, M. H., Souza, G. R. de, Cunha, T. M., Ferrari, L. F., Clemente-Napimoga, J. T., Parada, C. A., et al. (2008). 15d-Prostaglandin 'J IND. 2' inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Journal of Pharmacology and Experimental Therapeutics, 324( 1), 313-321.NLM
Napimoga MH, Souza GR de, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri Júnior WA, Cunha F de Q, Ferreira SH. 15d-Prostaglandin 'J IND. 2' inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Journal of Pharmacology and Experimental Therapeutics. 2008 ; 324( 1): 313-321.[citado 2024 ago. 22 ]Vancouver
Napimoga MH, Souza GR de, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri Júnior WA, Cunha F de Q, Ferreira SH. 15d-Prostaglandin 'J IND. 2' inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Journal of Pharmacology and Experimental Therapeutics. 2008 ; 324( 1): 313-321.[citado 2024 ago. 22 ]